Omega Healthcare Investors, Inc.

NYSE:OHI Stock Report

Market Cap: US$10.5b

Omega Healthcare Investors Valuation

Is OHI undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of OHI when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: OHI ($37.83) is trading below our estimate of fair value ($68.06)

Significantly Below Fair Value: OHI is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for OHI?

Key metric: As OHI is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for OHI. This is calculated by dividing OHI's market cap by their current earnings.
What is OHI's PE Ratio?
PE Ratio29.3x
EarningsUS$347.99m
Market CapUS$10.50b

Price to Earnings Ratio vs Peers

How does OHI's PE Ratio compare to its peers?

The above table shows the PE ratio for OHI vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average50x
DOC Healthpeak Properties
45.6x-21.8%US$14.4b
ARE Alexandria Real Estate Equities
61.3x18.5%US$17.3b
CTRE CareTrust REIT
51.9x45.0%US$5.1b
SBRA Sabra Health Care REIT
41.3x18.9%US$4.0b
OHI Omega Healthcare Investors
29.3x9.9%US$10.5b

Price-To-Earnings vs Peers: OHI is good value based on its Price-To-Earnings Ratio (29.3x) compared to the peer average (52.8x).

Price to Earnings Ratio vs Industry

How does OHI's PE Ratio compare vs other companies in the Global Health Care REITs Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
OHI 29.3xIndustry Avg. 24.9xNo. of Companies5PE020406080100+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: OHI is expensive based on its Price-To-Earnings Ratio (29.3x) compared to the Global Health Care REITs industry average (24.9x).

Price to Earnings Ratio vs Fair Ratio

What is OHI's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

OHI PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio29.3x
Fair PE Ratio38.2x

Price-To-Earnings vs Fair Ratio: OHI is good value based on its Price-To-Earnings Ratio (29.3x) compared to the estimated Fair Price-To-Earnings Ratio (38.2x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst OHI forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$37.83
US$42.60
+12.6%
7.6%US$49.00US$37.00n/a15
Dec ’25US$40.61
US$42.47
+4.6%
8.2%US$49.00US$35.00n/a15
Nov ’25US$41.20
US$41.07
-0.3%
9.9%US$49.00US$35.00n/a15
Oct ’25US$40.39
US$39.50
-2.2%
8.6%US$46.00US$34.00n/a14
Sep ’25US$39.54
US$38.69
-2.1%
7.2%US$44.00US$34.00n/a13
Aug ’25US$36.70
US$34.50
-6.0%
7.0%US$39.00US$30.00n/a14
Jul ’25US$33.97
US$33.36
-1.8%
7.4%US$38.00US$28.00n/a14
Jun ’25US$32.33
US$32.86
+1.6%
6.3%US$36.00US$28.00n/a14
May ’25US$30.69
US$32.79
+6.8%
7.4%US$37.00US$28.00n/a14
Apr ’25US$31.82
US$32.79
+3.0%
7.4%US$37.00US$28.00n/a14
Mar ’25US$31.00
US$32.53
+4.9%
8.0%US$37.00US$28.00n/a15
Feb ’25US$29.52
US$32.47
+10.0%
7.2%US$36.00US$28.00n/a15
Jan ’25US$30.66
US$32.43
+5.8%
6.9%US$36.00US$28.00n/a14
Dec ’24US$32.12
US$33.33
+3.8%
6.2%US$37.00US$30.00US$40.6115
Nov ’24US$33.24
US$34.20
+2.9%
6.2%US$38.00US$30.00US$41.2015
Oct ’24US$33.16
US$33.25
+0.3%
5.8%US$36.00US$30.00US$40.3914
Sep ’24US$32.70
US$32.19
-1.6%
6.7%US$36.00US$28.00US$39.5413
Aug ’24US$31.68
US$31.81
+0.4%
5.8%US$35.00US$28.00US$36.7013
Jul ’24US$30.69
US$31.09
+1.3%
6.2%US$33.00US$26.00US$33.9711
Jun ’24US$29.53
US$30.27
+2.5%
8.3%US$33.00US$25.00US$32.3311
May ’24US$26.75
US$29.55
+10.5%
11.1%US$36.00US$24.00US$30.6911
Apr ’24US$27.41
US$29.27
+6.8%
11.5%US$36.00US$24.00US$31.8211
Mar ’24US$26.67
US$29.25
+9.7%
11.0%US$36.00US$24.00US$31.0012
Feb ’24US$29.38
US$29.77
+1.3%
10.6%US$36.00US$25.00US$29.5213
Jan ’24US$27.95
US$32.23
+15.3%
6.5%US$36.00US$28.00US$30.6613
Dec ’23US$29.99
US$32.77
+9.3%
6.4%US$36.00US$28.00US$32.1213

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 02:09
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Omega Healthcare Investors, Inc. is covered by 35 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Amanda SweitzerBaird
David RodgersBaird
Steven ValiquetteBarclays